EVEX Drug Patent Profile
Which patents cover Evex, and what generic alternatives are available?
Evex is a drug marketed by Roche Palo and is included in two NDAs.
The generic ingredient in EVEX is estrogens, esterified. There is one drug master file entry for this compound. Additional details are available on the estrogens, esterified profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EVEX?
- What are the global sales for EVEX?
- What is Average Wholesale Price for EVEX?
Summary for EVEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | EVEX at DailyMed |
US Patents and Regulatory Information for EVEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche Palo | EVEX | estrogens, esterified | TABLET;ORAL | 084215-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche Palo | EVEX | estrogens, esterified | TABLET;ORAL | 083376-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
